HIV I Infection Clinical Trial
— YomelelaOfficial title:
Intervention to Improve HIV Care Retention and Antiretroviral Adherence in Stigmatized Environments
Verified date | October 2021 |
Source | University of Connecticut |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Retention in care and persistent adherence to antiretroviral therapy are necessary for the successful treatment of HIV infection. HIV-related stigma is a known impediment to the care and health outcomes of people living with HIV. The proposed study will test theory-based interventions designed to manage HIV stigma in order to improve care retention and medication adherence in communities with high-levels of HIV-related stigma.
Status | Recruiting |
Enrollment | 1200 |
Est. completion date | November 1, 2024 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. 18 years of age or older 2. current clinic visit to receive cART in differentiated care outside of an adherence club 3. unsuppressed HIV at the most recent clinical testing confirmed in run-in 4. access to a phone Exclusion Criteria: Not meeting inclusion |
Country | Name | City | State |
---|---|---|---|
United States | University of Connecticut Field Site | Atlanta | Georgia |
United States | University of Connecticut | Storrs | Connecticut |
Lead Sponsor | Collaborator |
---|---|
University of Connecticut | Medical Research Council, South Africa |
United States,
Kalichman SC, Mathews C, Banas E, Kalichman MO. Stigma management intervention to improve antiretroviral therapy adherence: Phase-I test of concept trial, Cape Town South Africa. Glob Public Health. 2019 Aug;14(8):1059-1074. doi: 10.1080/17441692.2018.1552307. Epub 2018 Nov 30. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Medical Records of Care Appointments | Medical records are retrospectively collected for all scheduled care visits and coded for whether the visits were attended.The records are exclusively from the clinic where patients are initially recruited and with patient permission. The data obtained are expressed as the ratio of the number of care appointments attended relative to the number scheduled. | 12-months | |
Primary | Blood Plasma RNA | Collection of dried blood spots are tested for HIV RNA (viral load) using PCR tests with results expressed as the number of RNA copies per mL of blood plasma. | 12-months | |
Secondary | Antiretroviral Medication Adherence | Monthly unannounced phone assessments are used to conduct pill counts of antiretroviral medications. The pill counts are used to calculate the proportion of pills taken relative to the number of pills prescribed over a 30 day period. | 12-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04585737 -
Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF
|
Phase 4 | |
Not yet recruiting |
NCT06282783 -
Studying Topiramate for Re-Activating the HIV-1 Reservoir
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03622177 -
Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection
|
||
Recruiting |
NCT05854381 -
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
|
Phase 1 | |
Enrolling by invitation |
NCT05071378 -
Leveraging Family-Based Assets for Black MSM In House Ball Communities
|
N/A | |
Completed |
NCT05421806 -
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/
|
||
Completed |
NCT04568395 -
Acute Effects of TCIG vs ECIG in PLWH
|
N/A | |
Recruiting |
NCT04887675 -
Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI
|
N/A | |
Recruiting |
NCT04820933 -
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
|
Early Phase 1 | |
Completed |
NCT03584048 -
Charlotte Retention in Care Study
|
||
Recruiting |
NCT06005610 -
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
|
Phase 2 | |
Recruiting |
NCT05947890 -
Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa
|
Phase 2 | |
Recruiting |
NCT05187429 -
Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05601128 -
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA
|
Phase 3 | |
Completed |
NCT04675255 -
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism
|
N/A | |
Completed |
NCT03986099 -
Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART
|
N/A | |
Completed |
NCT04971343 -
Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
|
||
Completed |
NCT04725877 -
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04618198 -
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
|
Phase 3 | |
Completed |
NCT05383456 -
The Visceral Adiposity Measurement and Observation Study
|